Haddasah Medical Organization firsts

Presentation hosted by Israel and Overseas committee and Hadassah

By Dr. Karen Ezrine

Did you know that one of the immunotherapy drugs used to treat macular degeneration and a number of cancers came out of research developed at Hadassah Medical Organization (HMO)? Avastin is only one of the breakthroughs developed by Hadassah researchers.

Hadassah, known for excellence in clinical care, education and research, collaborates with centers around the world and has developed breakthroughs that not only benefit the people of Israel but many others around the globe. During my talk of “Hadassah Firsts,” I will touch on just a few areas that make Hadassah among the leading centers in the world.

HMO has been cited by U.S. News and World Report as a leader in cardiology, oncology and smart tech. The dual robot system for treatment of complicated orthopedic procedures was first tested at Hadassah; other pharma and tech companies chose HMO as a partner to test new products and treatment modalities. Additionally, it is Hadassah to whom other countries turned for help in managing the COVID crisis; and Hadassah provided the first intake clinic in Poland to treat many Ukrainian refugees.

Israel is truly the “start-up nation” on so many levels.

Everyone is invited to hear more about these topics. Please join the Israel and Overseas Committee, Hadassah and the community on Thursday, March 28 at 2:30 p.m.

Please register for this free program at www.jewishnaples.org.